TMS in Borderline Personality Disorder Patients

Launched by INSTITUTO NACIONAL DE PSIQUIATRÍA DR. RAMÓN DE LA FUENTE · Oct 21, 2014

Keywords

ClinConnect Summary

This is a randomized, parallel group clinical trial to evaluate the efficacy of two protocols of repetitive Transcranial Magnetic Stimulation (rTMS), the application will be over dorsolateral prefrontal cortex (DLPFC) right and left, in patients with borderline personality disorder. 40 ambulatory patients with a borderline personality disorder diagnosis from the National Institute of Psychiatry in México will be included. All Patients will be randomly assigned and will complete a total of 23 sessions rTMS, in any of two groups:

5 Hz Group.- This group will receive rTMS sessions, 5 per week...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of borderline personality disorder according to diagnostic and statistical manual of mental disorders IV text revision
• • Treatment with selective inhibitors of serotonin reuptake
• • Mass corporal index more than 19
• Exclusion Criteria:
• • Suicide risk or suicide attempt recent or actual
• • History of epilepsy or seizures
• • History of cranial trauma with loss awareness
• • Intracranial or intraocular ferromagnetic devices, including skull prosthesis.
• • Pregnant womens.
• • Neurosurgery, cardiac pacemaker, lefthander
• • Patients with psychotic symptoms, bipolar disorder or substance addiction.

Trial Officials